175 related articles for article (PubMed ID: 12665806)
1. FDA panel recommends easing gene therapy trial limits.
Fox JL
Nat Biotechnol; 2003 Apr; 21(4):344-5. PubMed ID: 12665806
[No Abstract] [Full Text] [Related]
2. Cancer risk prompts US to curb gene therapy.
Check E
Nature; 2003 Mar; 422(6927):7. PubMed ID: 12621402
[No Abstract] [Full Text] [Related]
3. Safety panel backs principle of gene-therapy trials.
Check E
Nature; 2002 Dec; 420(6916):595. PubMed ID: 12478252
[No Abstract] [Full Text] [Related]
4. Cancer fears cast doubts on future of gene therapy.
Check E
Nature; 2003 Feb; 421(6924):678. PubMed ID: 12610583
[No Abstract] [Full Text] [Related]
5. Restoring public trust in gene therapy.
Kennedy EM
J Biolaw Bus; 2001; 4(3):3-4. PubMed ID: 12962103
[No Abstract] [Full Text] [Related]
6. Gene therapy. As Gelsinger case ends, gene therapy suffers another blow.
Couzin J; Kaiser J
Science; 2005 Feb; 307(5712):1028. PubMed ID: 15718439
[No Abstract] [Full Text] [Related]
7. US authorities uphold suspension of SCID gene therapy.
Fox JL
Nat Biotechnol; 2003 Mar; 21(3):217. PubMed ID: 12610555
[No Abstract] [Full Text] [Related]
8. Light, fast, and flexible: a new approach to regulation of human gene therapy.
Cregan JA
McGeorge Law Rev; 2000; 32(1):261-87. PubMed ID: 15709266
[No Abstract] [Full Text] [Related]
9. NIH panel may increase gene-trial scrutiny..
Smaglik P
Nature; 2000 Jun; 405(6788):724. PubMed ID: 10866166
[No Abstract] [Full Text] [Related]
10. The future of gene therapy.
Cavazzana-Calvo M; Thrasher A; Mavilio F
Nature; 2004 Feb; 427(6977):779-81. PubMed ID: 14985734
[No Abstract] [Full Text] [Related]
11. Gene therapists hopeful as trials resume with childhood disease.
Check E
Nature; 2004 Jun; 429(6992):587. PubMed ID: 15190314
[No Abstract] [Full Text] [Related]
12. NIH panel to limit secrecy on gene therapy.
Wadman M
Nature; 1999 Nov; 402(6757):6. PubMed ID: 10573406
[No Abstract] [Full Text] [Related]
13. New rules for gene-transfer trials.
Nelson RM
IRB; 2001; 23(6):11. PubMed ID: 12737176
[No Abstract] [Full Text] [Related]
14. New measures introduced to monitor gene therapy trials.
Hollon T
Nat Med; 2000 May; 6(5):486. PubMed ID: 10802682
[No Abstract] [Full Text] [Related]
15. Gene therapy. Seeking the cause of induced leukemias in X-SCID trial.
Kaiser J
Science; 2003 Jan; 299(5606):495. PubMed ID: 12543948
[No Abstract] [Full Text] [Related]
16. US panel advises resumption of gene trials.
Fox JL
Nat Biotechnol; 2002 Nov; 20(11):1068-9. PubMed ID: 12410240
[No Abstract] [Full Text] [Related]
17. Panel advises resuming genetic studies: U.S. agency halted trials after boy fell ill in French experiment.
Stolberg SG
N Y Times Web; 2002 Oct; ():A30. PubMed ID: 12474841
[No Abstract] [Full Text] [Related]
18. Tighter watch urged on adenoviral vectors...with proposal to report all 'adverse events'.
Smaglik P
Nature; 1999 Dec; 402(6763):707. PubMed ID: 10617181
[No Abstract] [Full Text] [Related]
19. Biotechnology on the RAC--FDA/NIH regulation of human gene therapy.
Rainsbury JM
Food Drug Law J; 2000; 55(4):575-600. PubMed ID: 12025851
[No Abstract] [Full Text] [Related]
20. Gene therapy. RAC's advice: proceed with caution.
Kaiser J
Science; 2002 Dec; 298(5601):2113-5. PubMed ID: 12481114
[No Abstract] [Full Text] [Related]
[Next] [New Search]
